Cargando…

A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols

BACKGROUND: The introduction of antibody markers to identify undesired cell populations in flow-cytometry based assays, so called DUMP channel markers, has become a practice in an increasing number of labs performing HLA-peptide multimer assays. However, the impact of the introduction of a DUMP chan...

Descripción completa

Detalles Bibliográficos
Autores principales: Attig, Sebastian, Price, Leah, Janetzki, Sylvia, Kalos, Michael, Pride, Michael, McNeil, Lisa, Clay, Tim, Yuan, Jianda, Odunsi, Kunle, Hoos, Axel, Romero, Pedro, Britten, Cedrik M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148571/
https://www.ncbi.nlm.nih.gov/pubmed/21745365
http://dx.doi.org/10.1186/1479-5876-9-108
_version_ 1782209364522696704
author Attig, Sebastian
Price, Leah
Janetzki, Sylvia
Kalos, Michael
Pride, Michael
McNeil, Lisa
Clay, Tim
Yuan, Jianda
Odunsi, Kunle
Hoos, Axel
Romero, Pedro
Britten, Cedrik M
author_facet Attig, Sebastian
Price, Leah
Janetzki, Sylvia
Kalos, Michael
Pride, Michael
McNeil, Lisa
Clay, Tim
Yuan, Jianda
Odunsi, Kunle
Hoos, Axel
Romero, Pedro
Britten, Cedrik M
author_sort Attig, Sebastian
collection PubMed
description BACKGROUND: The introduction of antibody markers to identify undesired cell populations in flow-cytometry based assays, so called DUMP channel markers, has become a practice in an increasing number of labs performing HLA-peptide multimer assays. However, the impact of the introduction of a DUMP channel in multimer assays has so far not been systematically investigated across a broad variety of protocols. METHODS: The Cancer Research Institute's Cancer Immunotherapy Consortium (CRI-CIC) conducted a multimer proficiency panel with a specific focus on the impact of DUMP channel use. The panel design allowed individual laboratories to use their own protocol for thawing, staining, gating, and data analysis. Each experiment was performed twice and in parallel, with and without the application of a dump channel strategy. RESULTS: The introduction of a DUMP channel is an effective measure to reduce the amount of non-specific MULTIMER binding to T cells. Beneficial effects for the use of a DUMP channel were observed across a wide range of individual laboratories and for all tested donor-antigen combinations. In 48% of experiments we observed a reduction of the background MULTIMER-binding. In this subgroup of experiments the median background reduction observed after introduction of a DUMP channel was 0.053%. CONCLUSIONS: We conclude that appropriate use of a DUMP channel can significantly reduce background staining across a large fraction of protocols and improve the ability to accurately detect and quantify the frequency of antigen-specific T cells by multimer reagents. Thus, use of a DUMP channel may become crucial for detecting low frequency antigen-specific immune responses. Further recommendations on assay performance and data presentation guidelines for publication of MULTIMER experimental data are provided.
format Online
Article
Text
id pubmed-3148571
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31485712011-08-03 A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols Attig, Sebastian Price, Leah Janetzki, Sylvia Kalos, Michael Pride, Michael McNeil, Lisa Clay, Tim Yuan, Jianda Odunsi, Kunle Hoos, Axel Romero, Pedro Britten, Cedrik M J Transl Med Research BACKGROUND: The introduction of antibody markers to identify undesired cell populations in flow-cytometry based assays, so called DUMP channel markers, has become a practice in an increasing number of labs performing HLA-peptide multimer assays. However, the impact of the introduction of a DUMP channel in multimer assays has so far not been systematically investigated across a broad variety of protocols. METHODS: The Cancer Research Institute's Cancer Immunotherapy Consortium (CRI-CIC) conducted a multimer proficiency panel with a specific focus on the impact of DUMP channel use. The panel design allowed individual laboratories to use their own protocol for thawing, staining, gating, and data analysis. Each experiment was performed twice and in parallel, with and without the application of a dump channel strategy. RESULTS: The introduction of a DUMP channel is an effective measure to reduce the amount of non-specific MULTIMER binding to T cells. Beneficial effects for the use of a DUMP channel were observed across a wide range of individual laboratories and for all tested donor-antigen combinations. In 48% of experiments we observed a reduction of the background MULTIMER-binding. In this subgroup of experiments the median background reduction observed after introduction of a DUMP channel was 0.053%. CONCLUSIONS: We conclude that appropriate use of a DUMP channel can significantly reduce background staining across a large fraction of protocols and improve the ability to accurately detect and quantify the frequency of antigen-specific T cells by multimer reagents. Thus, use of a DUMP channel may become crucial for detecting low frequency antigen-specific immune responses. Further recommendations on assay performance and data presentation guidelines for publication of MULTIMER experimental data are provided. BioMed Central 2011-07-11 /pmc/articles/PMC3148571/ /pubmed/21745365 http://dx.doi.org/10.1186/1479-5876-9-108 Text en Copyright ©2011 Attig et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Attig, Sebastian
Price, Leah
Janetzki, Sylvia
Kalos, Michael
Pride, Michael
McNeil, Lisa
Clay, Tim
Yuan, Jianda
Odunsi, Kunle
Hoos, Axel
Romero, Pedro
Britten, Cedrik M
A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols
title A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols
title_full A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols
title_fullStr A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols
title_full_unstemmed A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols
title_short A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols
title_sort critical assessment for the value of markers to gate-out undesired events in hla-peptide multimer staining protocols
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148571/
https://www.ncbi.nlm.nih.gov/pubmed/21745365
http://dx.doi.org/10.1186/1479-5876-9-108
work_keys_str_mv AT attigsebastian acriticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT priceleah acriticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT janetzkisylvia acriticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT kalosmichael acriticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT pridemichael acriticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT mcneillisa acriticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT claytim acriticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT yuanjianda acriticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT odunsikunle acriticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT hoosaxel acriticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT romeropedro acriticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT brittencedrikm acriticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT attigsebastian criticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT priceleah criticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT janetzkisylvia criticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT kalosmichael criticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT pridemichael criticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT mcneillisa criticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT claytim criticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT yuanjianda criticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT odunsikunle criticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT hoosaxel criticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT romeropedro criticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols
AT brittencedrikm criticalassessmentforthevalueofmarkerstogateoutundesiredeventsinhlapeptidemultimerstainingprotocols